| Literature DB >> 35276789 |
Siew Siew Lee1, Andrea McGrattan2, Yee Chang Soh1,3, Mawada Alawad1,3, Tin Tin Su1,3, Uma Devi Palanisamy4, Azizah Mat Hussin5, Zaid Bin Kassim6, Ahmad Nizal Bin Mohd Ghazali6, Blossom Christa Maree Stephan7, Pascale Allotey8, Daniel D Reidpath3,9, Louise Robinson10, Devi Mohan1, Mario Siervo11.
Abstract
The DePEC-Nutrition trial is a complex dietary and behavioural intervention of salt intake reduction combined with increased high-nitrate vegetable consumption among Malaysian middle-aged and older adults with elevated blood pressure. This study aimed to assess the feasibility and acceptability of the trial. Participants were recruited from the South East Asia Community Observatory (SEACO) database and randomised into one of four groups: (1) low salt; (2) high-nitrate vegetable; (3) combined high-nitrate vegetable and low salt; and (4) control. The intervention included a combination of group counselling sessions, information booklets, reinforcement videos and text messages to modify dietary behaviour. The primary outcomes evaluated were the measures of feasibility and acceptability of (1) recruitment, follow-up attendance and retention; (2) data collection procedures and clinical outcome measures; and (3) individual and combined multi-modal dietary interventions. A total of 74 participants were recruited, and the 10-month retention rate was 73%. Data collection procedures were acceptable with minimal missing data. All intervention strategies were feasible and acceptable, with group counselling being the most acceptable strategy. This study provides important insights into improving the screening process of participants, facilitating their access to the research facilities and refining the measurement protocols and dietary recommendations, which are instrumental in formulating the design of a full-scale definitive DePEC-Nutrition trial.Entities:
Keywords: dementia; dietary nitrate; feasibility trial; randomised controlled trial; reduced salt
Mesh:
Substances:
Year: 2022 PMID: 35276789 PMCID: PMC8839221 DOI: 10.3390/nu14030430
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Eligibility criteria for trial participants.
| Inclusion criteria |
Aged 50–75 years Live within 5 km radius from Health Clinic Sungai Segamat Systolic blood pressure 120–159 mmHg or diastolic blood pressure 80–99 mmHg BMI > 18.5 kg/m2 |
| Exclusion criteria |
Inability to consent Severe visual or hearing impairment Have functional impairment (Katz Index of Activities of Daily Living score < 6) Limited mobility due to any reason Current participation in other clinical studies Patients on any therapeutic diet, such as weight loss treatments or gluten-free diet Vegetarianism (likely to have a high intake of vegetables): Those who are strict vegetarians in their regular diet. Since Chinese and Indian participants are more likely to follow a vegetarian or semi-vegetarian diet, in order to maintain representativeness across ethnic groups included in the study, only participants on a strictly vegetarian diet (i.e., vegans) will be excluded from the study History of active cancer and any diagnosis of malignant cancer in the last 5 years History of excessive alcohol intake (>21 units of alcohol per week) Diagnosis of acute and chronic medical conditions interfering with the study outcomes, such as systemic infections, severe liver and kidney diseases, inflammatory bowel diseases, coronary heart diseases, cerebrovascular diseases or diabetes on insulin therapy Major surgical operations (recent/planned) interfering with the study outcomes Current diagnosis of moderate or severe depression, or other serious mental or brain disorders currently treated with psychiatric drugs (antidepressants, sedatives, antipsychotics) Subjects on sodium-altering drugs (angiotensin-converting-enzyme (ACE) inhibitors, diuretics), organic nitrates, proton-pump inhibitors, corticosteroids (systemic use only) Subjects on hormonal therapies (oestrogens, thyroxin and progesterone), antihypertensive (Ca++ channel blockers, beta-blockers) statins, oral anti-diabetic medications and any other antidyslipidemia agent Planning to move house in the next one year MMSE score ≤ 18 |
The outcome measures for the DePEC-Nutrition feasibility study.
| Outcome Measures | Description of Measures Used |
|---|---|
| Primary outcomes | |
| Screening, recruitment, follow-up rate and retention | Number screened: The number of people assessed for eligibility using inclusion/exclusion criteria. |
| Follow-up rate: The number of participants who were assessed during interim follow-ups. | |
| Suitability and acceptability of data collection procedures and outcomes measures | Self-rating appropriateness and suitability of intervention timing and location |
| Feasibility and acceptability of the intervention strategies | Engagement with the intervention: Meaningful engagement was determined by whether the information booklet provided was read by the participants. For the text messages and reinforcement video, engagement was determined by whether the participants opened, read and responded to the text messages and video. |
| Low salt and nitrate intervention | Participant self-rated acceptability of low salt diet |
| Outcomes for a definitive trial * | |
| Demographic and medical history | Demographic, medical and medication history |
| Health and lifestyle | Global Physical Activity Questionnaire (GPAQ), Global Activity Limitation Indicator (GALI), smoking and alcohol use, Geriatric Depression Scale (GDS) (short form) |
| Cognitive assessment | Montreal Cognitive Assessment (MoCA) test, Auditory Verbal Learning Test (AVLT), Trail Making Test Part B, Animal Naming Test |
| Blood pressure | Three consecutive measurements of resting blood pressure readings in a sitting position using OMRON automated monitor (OMRON HEM 907, OMRON Healthcare, Milton Keynes, UK) |
| Anthropometry and body composition | Height (m), weight (kg), BMI (kg/m2) and body composition were measured using a portable bioelectrical impedance analysis (BIA) scale (Tanita DC-430MA Body Composition Analyzer, Tanita Corporation, Japan) with a 0.1 kg precision |
| Functional performance | Hand grip strength dynamometer, 4-metre gait speed test, Timed Up and Go (TUG) test |
| Dietary assessment | Food Frequency Questionnaire, 24-h diet recall |
| Biological sample collection | 15 mL whole venous blood, 24-h urine sample, spot urine sample, whole saliva collected using passive drool technique, salivary strips and dried blood spot |
* These outcomes were collected at baseline only due to the COVID-19 pandemic and require further pilot testing in a definitive trial.
Figure 1The flow of participants through the pilot study.
The baseline characteristics of the participants.
| Characteristics a | Total | Low Salt | High-Nitrate Vegetable | High-Nitrate | Control | |
|---|---|---|---|---|---|---|
| Age, years | 61.6 ± 6.7 | 62.6 ± 7.2 | 61.9 ± 6.7 | 60.4 ± 7.3 | 61.0 ± 5.8 | 0.752 |
| Ethnicity | ||||||
| Malay | 51 (68.9) | 17 (73.9) | 9 (52.9) | 13 (76.5) | 12 (70.6) | 0.457 |
| Chinese | 23 (31.1) | 6 (26.1) | 8 (47.1) | 4 (23.5) | 5 (29.4) | |
| Sex: Male | 31 (41.9) | 7 (30.4) | 9 (52.9) | 9 (52.9) | 6 (35.3) | 0.386 |
| Employment status | ||||||
| Working, full-time/self-employed | 26 (35.1) | 6 (26.1) | 5 (29.4) | 11 (64.7) | 4 (23.5) | 0.075 |
| Working, part-time | 9 (12.2) | 5 (21.7) | 1 (5.9) | 0 (0.0) | 3 (17.6) | |
| Retired/Unemployed /Homemaker | 39 (52.7) | 12 (52.2) | 11 (64.7) | 6 (35.3) | 10 (58.8) | |
| Highest education level | ||||||
| No formal education | 6 (8.1) | 1 (4.3) | 2 (11.8) | 1 (5.9) | 2 (11.8) | 0.465 |
| Primary | 27 (36.5) | 10 (43.5) | 8 (47.1) | 3 (17.6) | 6 (35.3) | |
| Secondary | 36 (48.6) | 11 (47.8) | 6 (35.3) | 10 (58.8) | 9 (52.9) | |
| Tertiary and others | 5 (6.8) | 1 (4.3) | 1 (5.9) | 3 (17.6) | 0 (0.0) | |
| Marital status | ||||||
| Married | 62 (83.8) | 18 (78.3) | 14 (82.4) | 16 (94.1) | 14 (82.4) | 0.643 |
| Never married/Divorced/Widow/Widower | 12 (16.2) | 5 (21.7) | 3 (17.6) | 1 (5.9) | 3 (17.6) | |
| Current smoking (Yes) | 12 (16.2) | 4 (17.4) | 4 (23.5) | 2 (11.8) | 2 (11.8) | 0.841 |
| Current use of alcohol (Yes) | 8 (10.8) | 2 (8.7) | 4 (23.5) | 1 (5.9) | 1 (5.9) | 0.456 |
| BMI, kg/m2 | 27.5 ± 4.6 | 28.3 ± 5.5 | 27.2 ± 4.6 | 27.5 ± 3.4 | 26.9 ± 4.4 | 0.806 |
| Systolic blood pressure, mmHg | 135.9 ± 14.1 | 135.0 ± 15.3 | 136.6 ± 10.5 | 137.5 ± 16.5 | 134.9 ± 13.9 | 0.934 |
| Diastolic blood pressure, mmHg | 80.3 ± 9.7 | 81.1 ± 10.6 | 80.8 ± 5.8 | 79.5 ±12.3 | 79.6 ± 9.5 | 0.940 |
| Geriatric Depression Scale score | 4.0 (2.0, 5.0) | 4.0 (2.0, 5.5) | 4.0 (2.0, 5.0) | 3.0 (1.0, 4.0) | 2.5 (2.0, 4.3) | 0.227 |
| Grip strength, mm | 26.7 ± 9.5 | 26.2 ± 9.6 | 25.3 ± 9.1 | 29.0 ± 10.3 | 26.5 ± 9.3 | 0.698 |
| Physical activity, MET–mins/week | 2880 (710, 5415) | 2960 (660, 3840) | 1920 (420, 4620) | 5040 (760, 8840) | 3900 (1560, 10875) | 0.605 |
| Gait speed test, m/s ( | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.2 | 1.1 ± 0.2 | 0.9 ± 0.3 | 0.122 |
| Timed up and go, s ( | 9.8 (8.8, 11.8) | 9.6 (8.6, 11.5) | 9.3 (8.6, 11.0) | 11.4 (8.9, 12.1) | 10.2 (9.1, 10.2) | 0.283 |
| MoCA total score | 20.8 ± 4.0 | 20.3 ± 4.4 | 21.5 ± 4.0 | 20.6 ± 3.8 | 20.9 ± 3.9 | 0.834 |
| Trail Making Test B, s | 207 ± 86 | 221 ± 87 | 222 ± 95 | 194 ± 80 | 188 ± 83 | 0.518 |
| Animal Naming ( | 14.9 ± 4.2 | 15.8 ± 3.5 | 13.8 ± 3.5 | 14.1 ± 3.4 | 15.5 ± 5.8 | 0.337 |
| AVLT Trial 8, A7 (Delayed recall) | 6.7 ± 3.4 | 6.7 ± 2.8 | 5.9 ± 4.9 | 6.9 ± 2.6 | 7.3 ± 3.3 | 0.684 |
a Categorical variables are expressed as n (%) while continuous variables are expressed as the mean ± standard deviation (SD) for the normally distributed variables and as the median (Quartile 1, Quartile 3) for the non-normally distributed variables. A statistical analysis was conducted for comparing variables among the four groups using One—way ANOVA for the normally distributed continuous variables and Kruskal–Wallis for the non-normally distributed variables. The Chi-squared test and Fisher’s exact test were conducted for comparing categorical variables among the four groups. b Where measurements were not obtained in the full set of 74 participants, the exact number of participants for the variable is stated in brackets beside the variable name.
The quantitative and qualitative results regarding the acceptability of screening and recruitment.
| Category | Quantitative Data | Qualitative Data-Representative Quotes from Respondents and Data Collectors |
|---|---|---|
| Number of visits | Appropriate: 90.7% (49/54) | “ |
| Duration of visit | Appropriate: 84.9% (45/53) | “ |
| Location of the clinic | Convenient: 96.2% (50/52) | “ |
Figure 2The acceptability of the baseline assessments. Missing information: providing blood samples (n = 1); providing saliva sample (n = 1).
Summary of feasibility and acceptability of the intervention strategies.
| Intervention Strategy | Engagement with Intervention | Perceived Usefulness of Intervention Strategies (Qualitative Data) | |
|---|---|---|---|
| Theme Generated | Representative Quote’s | ||
| Group counselling sessions | All participants from the intervention groups ( |
Provide information on health and nutrition As a reminder Engagement with doctor Moderately useful | “ |
| Bi-weekly text message | Interim 1: |
A reminder Provide information and knowledge Follow up Moderately useful Poor delivery | “ |
| Reinforcement video | Interim 1: |
Poor delivery | “ |
| Interim 3: | |||
| Information booklet | At interim 2, at least 14 (31%) of 45 participants who completed the assessment admitted that they did not read the information booklet |
A guide A reminder Provide information Food choice | “ |
Figure 3The acceptability and suitability of the intervention materials. The response rate for each question was: 1 (n = 41/41); 2 (35/41); 3 (33/41); 4 (33/41); 5 to 8 (53/54). Question 1 to 4 was only applicable to the intervention groups (n = 41) and responded to by those engaged with the intervention strategies.
Figure 4The self-rated acceptability of low salt diet.